EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Blood transcriptomic signatures for symptomatic tuberculosis in an African multicohort study

Vanessa Mwebaza Muwanga iD, Simon C Mendelsohn, Vinzeigh Leukes, Kim Stanley, Stanley Kimbung Mbandi, Mzwandile Erasmus, Marika Flinn, Tarryn-Lee Fisher, Rodney Raphela, Nicole Bilek, Stephanus T Malherbe, Gerard Tromp und 5 weitere

European Respiratory Journal · 2024-08 · 64 (2) · 2400153

DOI: 10.1183/13993003.00153-2024 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Respiratory Journal, online erschienen am 04.07.2024. Verfasst von Vanessa Mwebaza Muwanga und 16 weiteren Autor:innen. Beteiligte Einrichtung: South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Patholog…. Hauptthemen laut MEDLINE: Transcriptome. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Division of Research Capacity Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multiple host blood transcriptional signatures have been developed as non-sputum triage tests for tuberculosis (TB). We aimed to compare the diagnostic performance of 20 blood transcriptomic TB signatures for differentiating between symptomatic patients who have TB versus other respiratory diseases (ORD).

Methods

As part of a nested case–control study, individuals presenting with respiratory symptoms at primary healthcare clinics in Ethiopia, Malawi, Namibia, Uganda, South Africa and The Gambia were enrolled. TB was diagnosed based on clinical, microbiological and radiological findings. Transcriptomic signatures were measured in whole blood using microfluidic real-time quantitative PCR. Diagnostic performance was benchmarked against the World Health Organization Target Product Profile (TPP) for a non-sputum TB triage test.

Results

Among 579 participants, 158 had definite, microbiologically confirmed TB, 32 had probable TB, while 389 participants had ORD. Nine signatures differentiated between ORD and TB with equivalent performance (Satproedprai7: area under the curve 0.83 (95% CI 0.79–0.87); Jacobsen3: 0.83 (95% CI 0.79–0.86); Suliman2: 0.82 (95% CI 0.78–0.86); Roe1: 0.82 (95% CI 0.78–0.86); Kaforou22: 0.82 (95% CI 0.78–0.86); Sambarey10: 0.81 (95% CI 0.77–0.85); Duffy9: 0.81 (95% CI 0.76–0.86); Gliddon3: 0.8 (95% CI 0.75–0.85); Suliman4 0.79 (95% CI 0.75–0.84)). Benchmarked against a 90% sensitivity, these signatures achieved specificities between 44% (95% CI 38–49%) and 54% (95% CI 49–59%), not meeting the TPP criteria. Signature scores significantly varied by HIV status and country. In country-specific analyses, several signatures, such as Satproedprai7 and Penn-Nicholson6, met the minimal TPP criteria for a triage test in Ethiopia, Malawi and South Africa.

Conclusion

No signatures met the TPP criteria in a pooled analysis of all countries, but several signatures met the minimum criteria for a non-sputum TB triage test in some countries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TranscriptomeHumansFemaleMaleAdultCase-Control StudiesMiddle AgedGambiaSouth AfricaEthiopiaMalawiUgandaTuberculosis, PulmonaryYoung AdultMycobacterium tuberculosisTuberculosisSensitivity and SpecificityNamibiaSputumReal-Time Polymerase Chain Reaction

Autor:innen und Institutionen

  • South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Immunology, Faculty of Medicine and Health Sciences, Stellenbosch U…
  • DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Healt…
  • South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa thomas.scriba@uct.…

ORCID-Profile: Vanessa Mwebaza Muwanga, Novel N Chegou, Thomas J Scriba

Förderung

  • Division of Research Capacity Development

Zitieren

APA

Muwanga, V. M., Mendelsohn, S. C., Leukes, V., Stanley, K., Mbandi, S. K., Erasmus, M., Flinn, M., Fisher, T. L., Raphela, R., Bilek, N., Malherbe, S. T., Tromp, G., Van Der Spuy, G., Walzl, G., Chegou, N. N., Scriba, T. J., & AE-TBC and ScreenTB Consortium (2024). Blood transcriptomic signatures for symptomatic tuberculosis in an African multicohort study. European Respiratory Journal, 64(2), 2400153. https://doi.org/10.1183/13993003.00153-2024

Vancouver

Muwanga VM, Mendelsohn SC, Leukes V, Stanley K, Mbandi SK, Erasmus M, et al. Blood transcriptomic signatures for symptomatic tuberculosis in an African multicohort study. European Respiratory Journal. 2024;64(2):2400153. doi:10.1183/13993003.00153-2024

BibTeX
@article{Muwanga2024,
  author = {Muwanga, Vanessa Mwebaza and Mendelsohn, Simon C and Leukes, Vinzeigh and Stanley, Kim and Mbandi, Stanley Kimbung and Erasmus, Mzwandile and Flinn, Marika and Fisher, Tarryn-Lee and Raphela, Rodney and Bilek, Nicole and Malherbe, Stephanus T and Tromp, Gerard and Van Der Spuy, Gian and Walzl, Gerhard and Chegou, Novel N and Scriba, Thomas J and AE-TBC and ScreenTB Consortium, AE-TBC and ScreenTB Consortium},
  title = {Blood transcriptomic signatures for symptomatic tuberculosis in an African multicohort study},
  journal = {European Respiratory Journal},
  year = {2024},
  volume = {64},
  number = {2},
  pages = {2400153},
  doi = {10.1183/13993003.00153-2024}
}
Kostenlos starten →